Historical collection · First published Jun 11, 2026; added to EM Weekly Oct 27, 2026. This retrospective summary may be superseded by later evidence or guidance.

← All articles
Randomized trialJAMA

Sodium Bicarbonate for In-Hospital Cardiac Arrest: A Randomized Clinical Trial

First online Jun 11, 2026On EM Weekly Oct 27, 2026Discovered Oct 27, 2026AI-generated Not yet human-reviewed

Summary

In this double-blind trial at 21 Danish hospitals, routine IV sodium bicarbonate did not improve sustained ROSC after in-hospital cardiac arrest. Of 913 randomized patients, 779 were eligible for the primary analysis.

Why it matters

The findings argue against routine empiric bicarbonate during in-hospital arrest. They do not resolve treatment for specific indications such as selected poisonings.

Study at a glance

Design
Randomized trial
Population
Adults with in-hospital arrest who had received at least one dose of epinephrine.
Sample size
779
Intervention
Up to 100 mmol IV sodium bicarbonate.
Comparator
IV placebo.
Primary endpoint
Sustained return of spontaneous circulation.

Main findings

  • Sustained ROSC: 39% versus 37%; RR 1.05 (95% CI 0.88-1.24).
  • Thirty-day survival: 12% versus 9.1%; RR 1.25 (95% CI 0.84-1.88).
  • Alkalosis and hypernatremia were more common with bicarbonate.

Limitations

Not powered to establish differences in survival or neurologic recovery. In-hospital arrest and postrandomization exclusions limit broader application.

Read the primary source

Full text: Abstract available; full text paywalled.

Original source

DOI: 10.1001/jama.2026.10628

PMID: 42273960

Source retrieved Oct 27, 2026. Abstract reviewed; full text unavailable. Publisher abstract and PubMed abstract reviewed. Publisher confirms June 11 first-online date. PMC manuscript was marked unavailable until December 11, 2026, so it was not treated as currently accessible.

Corrections & review history

No corrections recorded. Human review: not yet human-reviewed.